Intraoral stimulation of salivary secretion with the cholinesterase inhibitor physostigmine as a mouth spray: A pilot study in healthy volunteers

Archives of Oral Biology

Volumn 52, Issue 11, 2007, Pages 1097-1101

  Khosravani, Nina ^a   Ekström, Jörgen ^a   Birkhed, Dowen ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cholinesterase inhibitor; Dry mouth; Minor salivary glands; Mouth spray; Secretion

Indexed keywords

CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; MIDDLE AGED; MINOR SALIVA GLAND; NONPARAMETRIC TEST; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SALIVATION; STIMULATION;

ADOLESCENT; ADULT; BLOOD PRESSURE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; PHYSOSTIGMINE; PILOT PROJECTS; RESPIRATION; SALIVARY GLANDS, MINOR; SALIVATION; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL;

EID: 34848840906     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2007.06.003     Document Type: Article

References (13)

1. Ship J., Pillemer S.R., and Baum B.J. Xerostomia and the geriatric patient. J Am Geriatr Soc 50 (2002) 535-543
2. Permo Goldie M. Xerostomia and quality of life. Int J Dent Hyg 5 (2007) 60-61
3. Österberg T., Landahl S., and Hedegård B. Salivary flow, saliva pH and buffering capacity in 70-yr-old men and women. J Oral Rehab 11 (1984) 157-170
4. Nederfors T., Isaksson R., Mörnstad H., and Dahlöf C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population-relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25 (1997) 211-216
5. Hedner E., Birkhed D., Hedner J., Ekström J., and Helander H.F. Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man. Eur J Oral Sci 109 (2001) 371-374
6. Rossini R.B., Machado A.B., and Machado C.R.S. A histochemical study of catecholamines and cholinesterases in the autonomic nerves of human minor salivary glands. Histochem J 11 (1979) 661-668
7. Ekström J., and Helander H.F. Secretion from submucosal salivary glands of the ferret in response to a cholinesterase inhibitor applied onto the oral mucosa. Eur J Oral Sci 110 (2002) 230-236
8. Wynn R.L., Meiller T.F., and Crossley H.L. Drug information handbook for dentistry. Lexi-Comp's Dental Reference Library™. 12th ed. (2007), Lexi-Comp Inc.
9. Wiseman L.R., and Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 49 (1995) 143-155
10. Nordberg A., and Svensson A.-L. Cholinesterase inhibitors in the treatment of Alzheimer's disease. A comparison of tolerability and pharmacology. Drug Safety 19 (1998) 465-480
11. Sreebny L.M., and Broich G. Xerostomia (dry mouth). In: Sreebny L.M. (Ed). The salivary system (1988), CRC Press, Boca Raton, FL 179-202
12. Häupl K, Meyer W, Schuchardt K. Die Zahn-, Mund- und Kieferheilkunde, vol. 1, Anatomie, Physiologie, Pathologie. München, Berlin: Urban & Schwarzenberg; 1958.
13. Hartvig P., Wiklund L., and Lindström B. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients. Acta Anaesthesiol Scand 30 (1986) 177-182